---
title: "MOLECULE PHARMA LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/916010ff-8a93-5c99-8cbc-ff0fd86bbca2
json: https://whiteintel.dev/api/public/dossier/916010ff-8a93-5c99-8cbc-ff0fd86bbca2
identifier: oo:GB-COH-14284456
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MOLECULE PHARMA LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-14284456`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/916010ff-8a93-5c99-8cbc-ff0fd86bbca2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/916010ff-8a93-5c99-8cbc-ff0fd86bbca2  

## Ownership & control

### Owners / controllers

- **7K HEALTHCARE LTD** (beneficial owner) — 50% — https://whiteintel.dev/entity/984e5c22-58bc-51ec-b925-f9040cc37d03
- **ENZYMEX LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/5defef68-360e-5f39-8769-dcbbfb3bdcee
- **STU THE PHARMA LTD** (beneficial owner) — 50% — https://whiteintel.dev/entity/f5c4472d-9f15-59c2-ad6e-e27b33440bdb
- **7K HEALTHCARE LTD** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/984e5c22-58bc-51ec-b925-f9040cc37d03
- **STU THE PHARMA LTD** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/f5c4472d-9f15-59c2-ad6e-e27b33440bdb
- **ENZYMEX LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/5defef68-360e-5f39-8769-dcbbfb3bdcee

### UBO chain (walk to the ultimate owner)

A **12-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `14284456`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2022-08-09
- **Registered office:** 231 Kenton Road, Harrow, HA3 0HD, England
- **SIC:** 72200

### Officers

- SHAH, Pranav Pradipkumar — director · British · appointed 2022-08-09
- PATEL, Swapnkumar Mukeshbhai — director · Indian · appointed 2022-08-09 · resigned 2024-12-10

### Beneficial owners (Persons with Significant Control)

- [7k Healthcare Ltd](https://whiteintel.dev/entity/984e5c22-58bc-51ec-b925-f9040cc37d03) — 25–50% shares · corporate PSC · England — since 2022-11-01
- [Stu The Pharma Ltd](https://whiteintel.dev/entity/f5c4472d-9f15-59c2-ad6e-e27b33440bdb) — 25–50% shares · corporate PSC · England — since 2022-08-09
- [Enzymex Limited](https://whiteintel.dev/entity/5defef68-360e-5f39-8769-dcbbfb3bdcee) — 25–50% shares · corporate PSC · England — ceased 2022-11-01

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/14284456
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/14284456

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MOLECULE PHARMA LIMITED**. Human view: https://whiteintel.dev/entity/916010ff-8a93-5c99-8cbc-ff0fd86bbca2 · Structured JSON: https://whiteintel.dev/api/public/dossier/916010ff-8a93-5c99-8cbc-ff0fd86bbca2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._